EFFICIENCY AND SAFETY OF CHEMOTHERAPY REGIMEN WITH SQ109 IN THOSE SUFFERING FROM MULTIPLE DRUG RESISTANT TUBERCULOSIS

EFFICIENCY AND SAFETY OF CHEMOTHERAPY REGIMEN WITH SQ109 IN THOSE SUFFERING FROM MULTIPLE DRUG RESISTANT TUBERCULOSIS

The objective of the study: to assess efficiency and safety of SQ109 used within standard treatment regimens for multiple drug resistant tuberculosis (MDR TB)Subjects and Methods A multi-center, double, blind, randomized, placebo-controlled study was conducted in two parallel groups from September 2...

Full description

Bibliographic Details
Main Authors:	S. E. Borisov, E. M. Bogorodskaya, G. V. Volchenkov, E. V. Kulchavenya, A. O. Maryandyshev, S. N. Skornyakov, O. B. Talibov, A. M. Tikhonov, I. A. Vasilyeva
Format:	Article
Language:	Russian
Published:	New Terra Publishing House 2018-04-01
Series:	Туберкулез и болезни лёгких
Subjects:	препарат sq109 туберкулез легких множественная лекарственная устойчивость m. tuberculosis
Online Access:	https://www.tibl-journal.com/jour/article/view/1098

Similar Items

DRUG RESISTANCE OF STRAINS OF M. TUBERCULOSIS, ISOLATED FROM PULMONARY TUBERCULOSIS PATIENTS IN VLADIMIR REGION IN 2013
by: E. S. Dyuzhik, et al.
Published: (2015-10-01)

EXPERIENCE OF USING BEDAQUILINE AND LINEZOLID IN THE INTEGRAL TREATMENT OF THE PULMONARY TUBERCULOSIS PATIENT WITH EXTENSIVE DRUG RESISTANCE OF M. TUBERCULOSIS
by: E. M. Zhukova, et al.
Published: (2016-10-01)

Efficiency of surgical treatment of multidrug-resistant Pulmonary Tuberculosis within the DOTS-PLUS program
by: A. K. Strelis, et al.
Published: (2009-02-01)

ANALYSIS OF THE PATIENTS REFERRED FOR TREATMENT TO NOVOSIBIRSK TUBERCULOSIS RESEARCH INSTITUTE FROM THE AREAS SUPERVISED BY THIS INSTITUTE. CHANGES IN CHEMOTHERAPY EFFICIENCY AFTER INTRODUCTION OF THE UPDATED TREATMENT REGIMENS AND MICROBIOLOGICAL DIAGNOSTICS
by: E. P. Myshkova, et al.
Published: (2017-09-01)

Drug susceptibility of M. tuberculosis in tuberculosis patients from various population groups in Khanty-Mansiyskiy Autonomous Region
by: Yu. V. Reshetnikova, et al.
Published: (2015-11-01)

CLINICAL CASES OF FOCAL PULMONARY TUBERCULOSIS IN CHILDREN WITH MINIMUM INVOLVEMENT IN MULTIDRUG RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS
by: M. F. Gubkina, et al.
Published: (2015-03-01)

Prevalence of Extensively Drug-Resistant Tuberculosis: a Descriptive Study
by: O. A. Pasechnik, et al.
Published: (2018-09-01)

SURGERY FOR DRUG-RESISTANT DESTRUCTIVE PULMONARY TUBERCULOSIS
by: S. N. Skornyakov, et al.
Published: (2015-03-01)

Predictors of failure in treatment according program DOTS-PLUS in patients suffering from multidrug-resistant tuberculosis
by: I. G. Felker, et al.
Published: (2012-08-01)

EFFICIENCY OF INPATIENT TREATMENT OF TUBERCULOSIS PATIENTS WITH DRUG-RESISTANT TB
by: I. F. Kopylova, et al.
Published: (2013-02-01)

THE EFFICIENCY OF TREATMENT IN MULTIDRUG-RESISTANT TUBERCULOSIS PATIENTS REGISTERED IN 2010
by: S. A. Sterlikov, et al.
Published: (2014-03-01)

IMPACT OF MOLECULAR GENETIC METHODS ON THE INITIATION OF CHEMOTHERAPY IN MULTIPLE DRUG RESISTANTTUBERCULOSIS PATIENTS IN ARKHANGELSK REGION
by: P. I. Eliseev, et al.
Published: (2018-01-01)

CHANGES IN THE PREVALENCE OF DRUG RESISTANT TUBERCULOSIS
by: V. B. Galkin, et al.
Published: (2017-03-01)

EXPERIENCE OF USING THE TB DRUG OF PERCHLOZON IN TUBERCULOSIS PATIENTS WITH MULTIPLE DRUG RESISTANCE IN BURYATIA REPUBLIC
by: S. V. Nikolaeva
Published: (2015-10-01)

The multivariate analysis of results of bedaquiline use in the therapy of MDR/XDR pulmonary tuberculosis
by: N. V. Stavitskaya, et al.
Published: (2020-08-01)

Social aspects multi-drug resistant tuberculosis
by: O. V. Filinyuk, et al.
Published: (2012-08-01)

A CASE OF EFFECTIVE TREATMENT IN A PATIENT WITH MULTIDRUG-RESISTANT PULMONARY TUBERCULOSIS CONCURRENT WITH CHRONIC RENAL FAILURE AFTER KIDNEY TRANSPLANTATION
by: O. G. Komissarova, et al.
Published: (2014-02-01)

Apical pleurectomy as a technique of elimination of continuous exudation after pulmonary resection due to multiple drug resistant tuberculosis
by: S. A. Belov, et al.
Published: (2016-01-01)

Social and demographic factors contributing to the spread of multiple drug resistant tuberculosis in the Russian Federation: a systematic review
by: I. A. Bykov
Published: (2022-07-01)

EFFICIENCY OF ADDING AN IMMUNE RESTORATIVE AGENT TO THE CURRENT TREATMENT REGIMENS OF PULMONARYTUBERCULOSIS PATIENTS WITH DRUG RESISTANCE
by: E. M. Zhukovа, et al.
Published: (2018-01-01)

Differentiated Approaches to the Choice of Timing of Surgical Treatment for Intrathoracic Lymph Node Tuberculosis in Children during Increasing Incidence of Multiple Drug Resistant Tuberculosis
by: M. F. Gubkina, et al.
Published: (2022-08-01)

Activity of blood plasma adenosine deaminase and mononuclear cell lysates in pulmonary tuberculosis patients with different levels of resistance to anti-tuberculosis agents
by: O. O. Yanovich, et al.
Published: (2015-04-01)

Prospects for Expanding Drug Therapy for Multiple Drug Resistant and Extensively Drug Resistant Tuberculosis
by: G. N. Mozhokina, et al.
Published: (2022-04-01)

Risk factors for multiple drug resistant tuberculosis relapses
by: А. S. Аlliluev, et al.
Published: (2020-12-01)

Efcacy and safety of combination therapy with bedaquiline in a multimorbid HIV positive patient with multiple drug resistant tuberculosis
by: E. M. Zhukova, et al.
Published: (2022-07-01)

EXPERIENCE OF USING BEDAQUILINE IN THE TREATMENT OF PULMONARY TUBERCULOSIS PATIENTS WITH MULTIPLE ANDEXTENSIVE DRUG RESISTANCE
by: N. M. Konovаlovа, et al.
Published: (2018-01-01)

Long-term results of treatment in multidrug-resistant mycobacterium tuberculosis patients interrupting a chemotherapy cycle
by: A. I. Gaida, et al.
Published: (2014-12-01)

MULTIPLE DRUG RESISTANCE PROTEINS OF PULMONARY SOMATIC CELLS AND THEIR SPECIFIC EXPRESSION IN FIBROUS CAVERNOUS TUBERCULOSIS
by: M. V. Erokhina, et al.
Published: (2016-09-01)

Represented results tuberculosis lung patients with firsting MDR in Republic of Buryatia
by: S. V. Nikolayeva, et al.
Published: (2012-08-01)

PREVALENCE OF MUTATIONS IN THE GENES OF M. TUBERCULOSIS CODING THE DRUG RESISTANCE TO ISONIAZID AND RIFAMPYCIN AMONG URBAN AND RURAL POPULATIONS OF SARATOV REGION
by: T. Yu. Salina, et al.
Published: (2015-10-01)

TUBERCULOSIS CONTROL SITUATION IN TERRITORIES OF THE RUSSIAN FEDERATION SUPERVISED BY CENTRAL TUBERCULOSIS RESEARCH INSTITUTE, 2014-2015
by: V. V. Punga, et al.
Published: (2016-09-01)

Use of mesenchymal stem cells in therapy of tuberculosis
by: А. N. Remezova, et al.
Published: (2022-05-01)

The short-course chemotherapy in the treatment of multiple drug resistant tuberculosis in children with different HIV status
by: E. Yu. Zorkaltseva, et al.
Published: (2019-09-01)

ЭФФЕКТИВНОСТЬ ЛЕЧЕНИЯ РИФАМПИЦИН-УСТОЙЧИВОГО ТУБЕРКУЛЕЗА В СОЧЕТАНИИ С СИНДРОМОМ ЗАВИСИМОСТИ ОТ АЛКОГОЛЯ
by: Ю. А. Шейфер, et al.
Published: (2023-03-01)

EFFECTIVE WAYS OF SOLVING THE PROBLEM OF MULTUDRUG-RESISTANT TUBERCULOSIS IN THE REPUBLIC OF BELARUS
by: E. M. Skryagina, et al.
Published: (2014-03-01)

MARKERS OF INFLAMMATORY RESPONSE IN PATIENTS WITH DRUG RESISTANCE OF MYCOBACTERIUM TUBERCULOSIS
by: E. N. Belyaeva, et al.
Published: (2018-01-01)

Clinical and economic aspects of enhanced treatment efficacy of multiple drug resistant tuberculosis
by: Yu. M. Markelov, et al.
Published: (2020-10-01)

Diagnosis and clinical and X-ray characteristics of pulmonary tuberculosis in adolescents
by: M. V. Pavlova, et al.
Published: (2015-01-01)

DIFFICULTIES IN THE MANAGEMENT OF A PATIENT WITH MULTIDRUG-RESISTANT PULMONARY TUBERCULOSIS CONCURRENT WITH DIABETES MELLITUS
by: T. I. Petrenko, et al.
Published: (2014-05-01)

Safety of treatment regimens in multiple drug resistant tuberculosis patients compiled as per the new WHO recommendations as of 2019
by: D. A. Ivanova, et al.
Published: (2020-02-01)